New platform combines precision gene targeting with brain-wide delivery

A caller survey describes a cistron therapy strategy that uses the brain's ain glymphatic transport strategy to administer engineered viral vectors passim the brain. The attack addresses 2 large challenges successful neurological medicine—reaching therapeutic targets down the blood-brain obstruction and limiting unwanted effects elsewhere successful the body—and could pave the mode for caller treatments for diseases including aggregate sclerosis, Huntington's illness and uncommon puerility achromatic substance disorders.